Viewing Study NCT06795893

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2026-02-22 @ 7:26 PM
Study NCT ID: NCT06795893
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: The Anifrolumab PRIM Program
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic autoimmune disease View
None immunosuppressants View
None corticosteroids View
None human monoclonal antibody (IgG1ƙ mAb) View
None post Marketing Requirements (PMR) study View
None pregnancy View
None Systemic Lupus Erythematosus View